Last Updated on eMC 29-03-2016 View medicine  | AstraZeneca UK Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
  • Improved presentation of PIL

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - excipient warnings
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to side-effects

Reasons for adding or updating:

  • Change of trade or generic name

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information

Reasons for adding or updating:

  • Change to instructions about overdose
  • Change to side-effects

Reasons for adding or updating:

  • Change to date of revision

Reasons for adding or updating:

  • Improved Electronic Presentation

Reasons for adding or updating:

  • Update to PIL

Reasons for adding or updating:

  • No reasons supplied